Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001335524 | SCV001528690 | uncertain significance | X-linked intellectual disability, Cantagrel type | 2018-04-20 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Institute of Human Genetics, |
RCV001335524 | SCV002072551 | likely benign | X-linked intellectual disability, Cantagrel type | 2022-01-18 | criteria provided, single submitter | clinical testing | Criteria applied: BP4_SUP, BS2_SUP |
Labcorp Genetics |
RCV001871872 | SCV002209985 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004035792 | SCV003586922 | uncertain significance | not specified | 2024-09-20 | criteria provided, single submitter | clinical testing | The c.3728G>A (p.R1243H) alteration is located in exon 3 (coding exon 2) of the KIAA2022 gene. This alteration results from a G to A substitution at nucleotide position 3728, causing the arginine (R) at amino acid position 1243 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |